EarliPoint Health Launches Project ALIGN to Advance Objective Measurement and Outcomes in Autism Care

Learn More →

Articles

Exploring the science, practice, and people shaping the future of early developmental evaluation.

Before We Ask Children to Learn Socially, Are the Foundations in Place?

Dr. Cheryl Tierney from EarliPoint Health and Rose Griffin from ABA Speech came together around this topic because we both see value […]

…

Who Can Diagnose Autism? A Scope-of-Practice Reference for Providers

Autism is diagnosed by licensed clinicians whose scope of practice includes diagnosing medical and developmental conditions. In the United States, that means […]

…

Vineland-3 Scoring and Interpretation: A Clinician’s Guide

Vineland-3 scoring works in three layers. Each subdomain produces a v-scale score with a mean of 15 and a standard deviation of […]

…

Diabetes Has the HgbA1C. Blood Pressure Has the Cuff. What Does Autism Treatment Have?

One of the hallmarks of good medical care is the ability to measure progress objectively. When a child is treated for diabetes, […]

…

EarliPoint Health Launches Project ALIGN to Advance Objective Measurement and Outcomes in Autism Care

Leading autism service organizations join founding consortium to help shape the future of longitudinal developmental measurement PLYMOUTH, MN — July 28, 2026 — […]

…

Assessment Fatigue: Reducing the Testing Burden on Families

By the time a child has been in autism services for a couple of years, their family has usually answered the same […]

…
Request A Demo

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder